Central Pharmacy Service Centers That Achieve More for Health Systems

As pharmacy plays an increasingly crucial role in the growth and future of health systems, organizations need operating models that provide the infrastructure needed to standardize operations across the enterprise and scale pharmacy services more effectively. Far more than a centralized dispensing facility, a modern Central Pharmacy Service Center (CSC) serves as a strategic platform for financial health, operational resilience, and long-term transformation.

The previous article explores the evolution of the CSCs and the technological and operational capabilities that distinguish modern CSCs from traditional pharmacy models.

McKesson's value is grounded in decades of operating one of the largest pharmaceutical distribution networks in the world. That experience creates CSC designs that are operationally proven, scalable, and resilient. Rather than treating patient care as a bespoke model, McKesson partners with health systems to apply distribution-grade systems thinking to convert processes tested at national scale into health system–specific solutions.

Expecting More with a Modern CSC

The Financial Advantage

By supporting expansion into specialty pharmacy, infusion, and other high-value service lines, CSCs position health systems to capture a greater share of pharmaceutical revenue while reducing barriers to entry. Centralized infrastructure allows these services to scale more efficiently and accelerates time to market, particularly for complex therapies where operational readiness is critical to participation. At the same time, standardized and automated workflows and demand-based staffing reduce cost per prescription as volume increases, creating operating leverage that supports margin expansion.

CSCs also enable more efficient deployment of capital and improve financial stability across the enterprise. Rather than investing in duplicative infrastructure at the site level, organizations can leverage shared assets such as compounding facilities, automation, and distribution capabilities. This model reduces redundancy while improving overall asset utilization. In parallel, centralized purchasing, inventory optimization, and alignment between procurement and utilization help reduce waste, minimize leakage, and strengthen negotiating leverage. Together, these factors create a more scalable and resilient financial model that supports both growth and long-term margin performance.

The Operational Advantage

Across health system operations, CSCs improve consistency and performance by reducing variability in how medications are prepared, verified, and delivered. Standardized workflows and centralized oversight lead to more predictable turnaround times, fewer errors, and improved overall reliability. Centralized staffing models allow labor to be flexed across the enterprise based on demand, mitigating local workforce constraints while improving productivity. This shift from site-based to system-based operations enables organizations to better manage fluctuations in volume without compromising service levels.

CSCs also streamline operations at the site level by removing high-volume, non-patient-facing activities from hospitals and clinics. This reduces congestion, frees up space, and simplifies inventory management, allowing frontline teams to focus more directly on patient care. Centralized control of inventory and allocation further ensures that medications are positioned where they are needed, which is particularly critical during shortages. Collectively, these capabilities create a more dependable and coordinated operating model, enhancing both system performance and the ability to respond to ongoing operational pressures.

5 Recommendations to Achieve More with a Central Pharmacy Service Center

1. Reframe CSCs as enterprise infrastructure. Health systems must move beyond the perception of CSCs as operational projects or facility investments. Focus instead on positioning within the organization's strategic planning framework alongside other enterprise-critical platforms such as Electronic Health Records, supply chain networks, and clinical service lines. This reframing changes how leadership evaluates, funds, and governs the CSC, which shifts the conversation from departmental cost savings to enterprise-wide capability building. When CSCs are treated as infrastructure, they receive the executive sponsorship, cross-functional alignment, and sustained investment required to deliver transformational impact over incremental
2. Build modular platforms that adapt to organizational growth. CSC design should resist the temptation to solve today's volumes alone. Adopting modular architectures allows capabilities to be activated, scaled, and reconfigured as strategic priorities emerge. This includes designing physical space, automated systems, and operational workflows with future expansion in mind. A modular approach reduces the risk of stranded capital, shortens the timeline for launching new services, and ensures the CSC remains aligned with the organization's growth trajectory rather than becoming a
3. Align technology and automation with clinical strategy. Technology investments within the CSC should be driven by clinical and operational priorities, not by vendor availability or automation trends in isolation. This means selecting and sequencing technology deployments, robotics, AI-driven forecasting, and interoperability platforms based on where they will create the most meaningful impact on patient outcomes and the health Automation eliminates manual variability and free clinical resources, while analytics platforms should be designed to inform decision-making at the enterprise level. When technology is anchored to clinical strategy, it accelerates the CSC's ability to function as a true enterprise platform rather than a technologically advanced but strategically disconnected facility.
4. Prioritize analytics, governance, and standardization early. One of the most common missteps in CSC development is deferring governance and analytics capabilities until after operations are established. In practice, these elements should be among the first to be designed and implemented. Governance structures including clear decision rights, escalation pathways, and cross-functional oversight committees establish the organizational discipline required to operate at enterprise scale. Analytics provide the visibility necessary to manage performance, anticipate demand, and respond to disruption. Standardization of workflows, formulary management, and inventory protocols ensures consistency across the network from the outset.
   Organizations that delay these foundational elements often find themselves retrofitting governance onto operations that have already developed inconsistent practices, significantly increasing the cost and complexity of alignment.
5. Evaluate CSCs through long-term strategic value, not short-term cost savings. Many limit the business case for CSCs to near-term labor reduction or operational consolidation metrics. However, it should center on total enterprise value creation over a multi-year horizon. Focus on quantifying revenue enablement through specialty pharmacy and infusion expansion, disruption avoidance through improved supply chain resilience, workforce transformation benefits, and the strategic optionality created by scalable infrastructure. Organizations that evaluate CSCs solely through a cost-savings lens risk underinvest in capabilities that drive long-term competitive A more comprehensive valuation framework that accounts for growth, resilience, and clinical impact alongside efficiency ensures that the CSC is resourced appropriately and a driver of continuous organizational performance.

As pharmacy operations become more complex and care continues to move beyond the traditional hospital setting, legacy site-based models are no longer sufficient. Central Pharmacy Service Centers provide the structural foundation needed to coordinate across fragmented care environments, standardize execution, and manage increasing operational and financial pressures with greater control and visibility.

Today’s question is no longer whether the CSC is needed, but whether organizations are prepared to design them in a way that fully captures their strategic potential.